Endogenous cannabinoid system as a modulator of food intake

被引:234
作者
Cota, D
Marsicano, G
Lutz, B
Vicennati, V
Stalla, GK
Pasquali, R
Pagotto, U
机构
[1] St Orsola Marcello Malpighi Hosp, CRBA,Ctr Appl Biomed Res, Dept Internal Med & Gastroenterol, Endocrinol Unit, I-40138 Bologna, Italy
[2] Max Planck Inst Psychiat, Neuroendocrinol Grp, D-80804 Munich, Germany
[3] Max Planck Inst Psychiat, Mol Genet Behav Grp, D-80804 Munich, Germany
关键词
endocannabinoids; anandamide; obesity; Cannabis; SR141716A; food intake;
D O I
10.1038/sj.ijo.0802250
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The ability of Cannabis sativa (marijuana) to increase hunger has been noticed for centuries, although intensive research on its molecular mode of action started only after the characterization of its main psychoactive component Delta(9)-tetrahydrocannabinol in the late 1960s. Despite the public concern related to the abuse of marijuana and its derivatives, scientific studies have pointed to the therapeutic potentials of cannabinoid compounds and have highlighted their ability to stimulate appetite, especially for sweet and palatable food. Later, the discovery of specific receptors and their endogenous ligands (endocannabinoids) suggested the existence of an endogenous cannabinoid system, providing a physiological basis for biological effects induced by marijuana and other cannabinoids. Epidemiological reports describing the appetite-stimulating properties of cannabinoids and the recent insights into the molecular mechanisms underlying cannabinoid action have proposed a central role of the cannabinoid system in obesity. The aim of this review is to provide an extensive overview on the role of this neuromodulatory system in feeding behavior by summarizing the most relevant data obtained from human and animal studies and by elucidating the interactions of the cannabinoid system with the most important neuronal networks and metabolic pathways involved in the control of food intake. Finally, a critical evaluation of future potential therapeutical applications of cannabinoid antagonists in the therapy of obesity and eating disorders will be discussed.
引用
收藏
页码:289 / 301
页数:13
相关论文
共 125 条
  • [71] Δ9-THC stimulates food intake in Lewis rats -: Effects on chow, high-fat and sweet high-fat diets
    Koch, JE
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2001, 68 (03) : 539 - 543
  • [72] Novel physiologic functions of endocannabinoids as revealed through the use of mutant mice
    Kunos, G
    Bátkai, S
    [J]. NEUROCHEMICAL RESEARCH, 2001, 26 (8-9) : 1015 - 1021
  • [73] Lan R, 1999, AAPS PharmSci, V1, pE4
  • [74] AM630 is an inverse agonist at the human cannabinoid CB1 receptor
    Landsman, RS
    Makriyannis, A
    Deng, HF
    Consroe, P
    Roeske, WR
    Yamamura, HI
    [J]. LIFE SCIENCES, 1998, 62 (09) : PL109 - PL113
  • [75] LANZOTTI VJ, 1977, CANCER, V39, P303, DOI 10.1002/1097-0142(197701)39:1<303::AID-CNCR2820390147>3.0.CO
  • [76] 2-U
  • [77] Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice
    Ledent, C
    Valverde, O
    Cossu, C
    Petitet, F
    Aubert, LF
    Beslot, F
    Böhme, GA
    Imperato, A
    Pedrazzini, T
    Roques, BP
    Vassart, G
    Fratta, W
    Parmentier, M
    [J]. SCIENCE, 1999, 283 (5400) : 401 - 404
  • [78] Molecular biology of cannabinoid receptors
    Lutz, B
    [J]. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2002, 66 (2-3): : 123 - 142
  • [79] INHIBITION OF NORMAL GROWTH BY CHRONIC ADMINISTRATION OF DELTA-9-TETRAHYDROCANNABINOL
    MANNING, FJ
    MCDONOUG.JH
    ELSMORE, TF
    SALLER, C
    SODETZ, FJ
    [J]. SCIENCE, 1971, 174 (4007) : 424 - &
  • [80] Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain
    Marsicano, G
    Lutz, B
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 1999, 11 (12) : 4213 - 4225